Drug exposure: Inclusion of dispensed drugs before pregnancy may lead to underestimation of risk associations

Journal of Clinical Epidemiology

Volumn 66, Issue 9, 2013, Pages 964-972

  Skurtveit, Svetlana ^a,b   Selmer, Randi ^a   Tverdal, Aage ^a   Furu, Kari ^a,c   Nystad, Wenche ^a   Handal, Marte ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Misclassification; MoBa; Pregnancy; Prescription databases; SSRI exposure; Validity

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN DISEASE; NORWAY; PERINATAL DRUG EXPOSURE; PERSISTENT PULMONARY HYPERTENSION; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; SELF REPORT; SENSITIVITY AND SPECIFICITY; STANDARD; VALIDATION STUDY;

MISCLASSIFICATION; MOBA; PREGNANCY; PRESCRIPTION DATABASES; SSRI EXPOSURE; VALIDITY;

ADULT; ANTIDEPRESSIVE AGENTS; DATABASES, FACTUAL; DEPRESSION; FEMALE; HUMANS; INFANT, NEWBORN; NORWAY; ODDS RATIO; PERSISTENT FETAL CIRCULATION SYNDROME; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PRESCRIPTION DRUGS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS;

EID: 84882908345     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2013.02.011     Document Type: Article

References (23)

1. D.E. Stewart Clinical practice. Depression during pregnancy N Engl J Med 365 2011 1605 1611
2. D.B. Davalos, C.A. Yadon, and H.C. Tregellas Untreated prenatal maternal depression and the potential risks to offspring: a review Arch Womens Ment Health 15 2012 1 14
3. W.O. Cooper, M.E. Willy, S.J. Pont, and W.A. Ray Increasing use of antidepressants in pregnancy Am J Obstet Gynecol 196 2007 544 545
4. G. Koren, and H. Nordeng Antidepressant use during pregnancy: the benefit-risk ratio Am J Obstet Gynecol 207 2012 157 163
5. F. Oyebode, A. Rastogi, G. Berrisford, and F. Coccia Psychotropics in pregnancy: safety and other considerations Pharmacol Ther 135 2012 71 77
6. H. Kieler, M. Artama, A. Engeland, O. Ericsson, K. Furu, and M. Gissler Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries BMJ 344 2012 d8012
7. G. Koren, and H. Nordeng SSRIs and persistent pulmonary hypertension of the newborn BMJ 344 2012 d7642
8. P. Magnus, L.M. Irgens, K. Haug, W. Nystad, R. Skjaerven, and C. Stoltenberg Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa) Int J Epidemiol 35 2006 1146 1150
9. P. Sarangarm, B. Young, W. Rayburn, P. Jaiswal, M. Dodd, and S. Phelan Agreement between self-report and prescription data in medical records for pregnant women Birth Defects Res A Clin Mol Teratol 94 2012 153 161
10. K. Furu, B. Wettermark, M. Andersen, J.E. Martikainen, A.B. Almarsdottir, and H.T. Sorensen The Nordic countries as a cohort for pharmacoepidemiological research Basic Clin Pharmacol Toxicol 106 2010 86 94
11. L.E. Grzeskowiak, A.L. Gilbert, and J.L. Morrison Exposed or not exposed? Exploring exposure classification in studies using administrative data to investigate outcomes following medication use during pregnancy Eur J Clin Pharmacol 68 2012 459 467
12. WHO Collaborating Centre for Drug Statistics Methodology ATC classification index with DDDs 2010 2010 WHO Collaborating Centre for Drug Statistics Methodology Oslo, Norway
13. L.M. Irgens The Medical Birth Registry of Norway. Epidemiological research and surveillance throughout 30 years Acta Obstet Gynecol Scand 79 2000 435 439
14. Questionnaires [Norwegian Institute of Public Health]. [updated 2010]. Available at http://www.fhi.no/. Accessed May 8, 2013.
15. S. Greenland Basic methods for sensitivity analysis of biases Int J Epidemiol 25 1996 1107 1116
16. The Stata Journal [The Stata Press].8, Number 129-148. [updated 2008]. [cited 3-9-0012]. Available at http://www.stata-journal.com/. Accessed May 8, 2013.
17. R.M. Nilsen, S.E. Vollset, H.K. Gjessing, R. Skjaerven, K.K. Melve, and P. Schreuder Self-selection and bias in a large prospective pregnancy cohort in Norway Paediatr Perinat Epidemiol 23 2009 597 608
18. A.A. Mitchell, L.B. Cottler, and S. Shapiro Effect of questionnaire design on recall of drug exposure in pregnancy Am J Epidemiol 123 1986 670 676
19. Selected special methodologic issues in pharmacoepidemiology B.L. Strom Pharmacoepidemiology 4th ed 2006 John Wiley & Sons England 555 832
20. M.G. Espnes, T. Bjorge, and A. Engeland Comparison of recorded medication use in the Medical Birth Registry of Norway with prescribed medicines registered in the Norwegian Prescription Database Pharmacoepidemiol Drug Saf 20 2011 243 248
21. B. Kallen, E. Nilsson, and P.O. Olausson Antidepressant use during pregnancy: comparison of data obtained from a prescription register and from antenatal care records Eur J Clin Pharmacol 67 2011 839 845
22. C. Olesen, C. Sondergaard, N. Thrane, G.L. Nielsen, L. de Jong-van den Berg, and J. Olsen Do pregnant women report use of dispensed medications? Epidemiology 12 2001 497 501
23. O. Stephansson, F. Granath, T. Svensson, B. Haglund, A. Ekbom, and H. Kieler Drug use during pregnancy in Sweden - assessed by the Prescribed Drug Register and the Medical Birth Register Clin Epidemiol 3 2011 43 50